Danish pharmaceuticals giant Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, said on Wednesday it was abandoning plans for a new factory in Denmark to make drugs for rare diseases, citing "shifts in global demand".
2 days ago